Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 119 participants.

Also called NCT06852079

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 119 participants (planned count) (from the registry)
Sponsor
Abdul Bari (from the registry)
Registry
  • NCT NCT06852079
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06852079. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-23 (actual); primary completion 2025-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
Condition
Hypertension
Intervention (Other)
Qurs e Fishar
Lead sponsor
Abdul Bari (class: other)
Collaborator
Hamdard University (class: other)

Record details

Record id
cardio:ct-nct06852079
Content hash
f0adc4efbde7db4583c6a3b8908dbd429bca15a48f868c5c222942bdfb1968bd